News

AroCell TK 210 ELISA can now be used on automated platforms

Oct 28, 2020

Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay.

We have now validated AroCell TK 210 ELISA for use on an automation platform, the Crocodile 5-in-1 ELISA mini workstation. This confirms that our product can both be used in manual operation as well as in automated operation mode. AroCell TK 210 ELISA shows similar high performance in terms of precision and sensitivity when used in this automated system as when run in manual mode, providing maximum flexibility for our customers.

Using AroCell TK 210 ELISA on an automation platform makes it easier than ever to measure levels of Thymidine kinase 1 (TK1) in blood samples (serum or Lithium-heparin plasma) for clinical use or in cell culture and xenografts models during drug development. AroCell TK 210 ELISA measures the concentration of TK1 by immunoassay and detects both active and inactive TK1, does not cross-react with TK2, or with non-human TK1.

Read more about AroCell TK 210 ELISA

IDL Diagnostics at EAU26

IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research. A big thank you to everyone we met at EAU26! We...

read more

IDL Diagnostics and concile at WHX Labs Dubai

Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection,...

read more